Early airway innate immune responses to F. tularensis
对土拉弗朗西斯菌的早期气道先天免疫反应
基本信息
- 批准号:7920676
- 负责人:
- 金额:$ 33.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAcuteAerosolsAlveolarAlveolar MacrophagesAntigensApoptosisAttenuated VaccinesBreathingCaspase-1Cell DeathCellsCessation of lifeColony-forming unitsComplementDefectDendritic CellsDepressed moodDetergentsDevelopmentDiseaseDisease OutbreaksElementsEndothelial CellsEpithelialEpithelial CellsEpitheliumFrancisella tularensisGelatinase BGram-Negative BacteriaHomeostasisHost DefenseHumanImmuneImmune responseImmunologicsInfectionInflammatory ResponseInstructionInterventionInvadedLungLung diseasesMatrix MetalloproteinasesMediatingMembraneNADPH OxidaseOrganismOutcomePathogenesisPathogenicityPathway interactionsPhenotypePneumoniaPropertyReactive Oxygen SpeciesRecruitment ActivityResistanceRouteSkinSterilitySurfaceTestingVirulenceVirulentaerosolizedantimicrobialassaultbasecapsulecaspase-3chemokineextracellularhuman diseaseinnate immune functioninsightmethionyl-leucyl-phenylalaninemicrobialneutrophilnovelnovel therapeuticspreventprophylacticresponsesuccesstransmission process
项目摘要
PROJECT SUIVIMARY (See instructions):
Francisella tularensis (Ft) is an intracellular Gram-negative bacterium that is highly pathogenic when
aerosolized. We reason that the remarkable pathogenicity of aerosolized Ft reflects unique microbial
features that render local innate host defenses in the lung quantitatively or qualitatively ineffective and
hypothesize that specific surface features of Ft, including extracellular capsule-like material (CLM),
subvert local pulmonary innate defenses, resulting in blunted host response in the lung and
consequently the observed virulence of aerosolized Ft. As part of our comprehensive assessment of
Ft-ain/vay innate host defense interaction and the contribution of CLM, Project 2 will examine alveolar
epithelial cells (AEC), pulmonary microvascular endothelial cells (PMVEC) and neutrophils that traverse Ftstimulated AEC and PMVEC (rPMN) - three interconnected elements of early pulmonary innate host response. We will pursue the following two aims:
Aim 1: To characterize the mechanisms and functional consequences of Ft resistance to
endogenous pulmonary alveolar epithelial and endothelial cell defenses
Do invading Ft or its CLM alter innate antimicrobial and proinflammatory responses of AEC and PMVEC? Do invading Ft alter PECAM-CD99 interactions involved in transmigration? Does Ft infection of AEC and PMVEC activate the inflammasome? Do interactions of AEC or PMVEC with Ft alter microbial phenotype and do such changes influence virulence? How do structural changes in CLM influence interactions between Ft and AEC or PMVEC and thereby alter PMN transmigration? How do ainway dendritic cells influence Ft invasion of AEC and AEC responses to invasion?
Aim 2: To define the functional alterations In transmigrated PMN recruited by Ft that contribute to
Ft virulence Does development of the rPMN phenotype require contact with Ft, shed bacterial components such as CLM, PMVEC-specific factor(s), or a combination of these elements? Does a similar phenotype develop in PMN that migrate across AEC? What is the functional phenotype of rPMN? What mechanism(s) underlie the depressed NADPH oxidase of rPMN? Do structural changes in Ft CLM alter interactions of Ft with PMVEC/AEC with subsequent effects on rPMN? Do rPMN that ingest Ft progress normally to undergo caspase-3-mediated apoptosis or are they redirected to a caspase-1-mediated proinflammatory cell death?
Suivimary项目(请参阅说明):
弗朗西斯菌(Francisella toarlensis)(ft)是一种细胞内革兰氏阴性细菌,当时是高度致病性的
雾化。我们认为,雾化FT的显着致病性反映了独特的微生物
在定量或定性无效的肺中导致本地先天宿主防御的功能
假设FT的特定表面特征,包括细胞外胶囊样材料(CLM),
颠覆局部肺先天防御,导致肺部的宿主反应钝化
因此,观察到的雾化ft的毒力。作为我们全面评估的一部分
ft-ain/vay先天主机防御互动和CLM的贡献,项目2将检查肺泡
上皮细胞(AEC),肺微血管内皮细胞(PMVEC)和中性粒细胞遍及FtStimentimentimentimentimentimentimentimentimentime ftStimentimeAC和PMVEC(rpmn) - 早期肺育宿主反应的三个相互连接的元素。我们将追求以下两个目标:
目标1:表征FT抵抗的机制和功能后果
内源性肺肺泡上皮和内皮细胞防御
入侵FT或其CLM会改变AEC和PMVEC的先天抗菌和促炎反应吗?入侵ft Alter Alter Pecam-CD99与移民有关的相互作用? FT感染AEC和PMVEC会激活炎症体吗? AEC或PMVEC与FT的相互作用是否改变了微生物表型并会影响毒力吗? CLM的结构变化如何影响FT与AEC或PMVEC之间的相互作用,从而改变PMN转移? Ainway树突状细胞如何影响AEC的FT侵袭和AEC对侵袭的反应?
目的2:定义FT招募的转移PMN的功能改变,这有助于
FT毒力是否需要与FT,脱落细菌成分(例如CLM,PMVEC特异性因子)或这些元素组合的细菌成分接触? PMN中类似的表型是否跨AEC迁移? RPMN的功能表型是什么? RPMN的抑郁NADPH氧化酶是什么机制? FT CLM的结构变化是否改变了FT与PMVEC/AEC的相互作用,随后对RPMN产生影响? RPMN是否会摄入FT通常会进展为caspase-3介导的细胞凋亡,还是将其重定向到caspase-1介导的促炎细胞死亡?
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William M. Nauseef其他文献
Immunochemical and Electrophoretic Analyses of Phosphorylated Native and Recombinant Neutrophil Oxidase Component p47-<em>Phox</em>
- DOI:
10.1182/blood.v76.12.2622.2622 - 发表时间:
1990-12-15 - 期刊:
- 影响因子:
- 作者:
William M. Nauseef;Bryan D. Volpp;Robert A. Clark - 通讯作者:
Robert A. Clark
755: Neutrophil Stimulation with Mycobacterium Bovis Bacillus Calmette-Guérin (BCG) Results in the Upregulation of Surface-Bound and Soluble Functional TRAIL/APO-2L
- DOI:
10.1016/s0022-5347(18)34924-3 - 发表时间:
2005-04-01 - 期刊:
- 影响因子:
- 作者:
Thomas S. Griffith;Troy J. Kemp;Aaron T. Ludwig;James K. Earel;Jill M. Moore;Bonita Moses;William M. Nauseef - 通讯作者:
William M. Nauseef
William M. Nauseef的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William M. Nauseef', 18)}}的其他基金
Determinants of human neutrophil fate after phagocytosis
吞噬作用后人类中性粒细胞命运的决定因素
- 批准号:
10092904 - 财政年份:2018
- 资助金额:
$ 33.77万 - 项目类别:
Determinants of human neutrophil fate after phagocytosis
吞噬作用后人类中性粒细胞命运的决定因素
- 批准号:
10328225 - 财政年份:2018
- 资助金额:
$ 33.77万 - 项目类别:
Consequences of interactions between human neutrophils and Staphylococcus aureus
人类中性粒细胞和金黄色葡萄球菌之间相互作用的后果
- 批准号:
9131612 - 财政年份:2015
- 资助金额:
$ 33.77万 - 项目类别:
Consequences of interactions between human neutrophils and Staphylococcus aureus
人类中性粒细胞和金黄色葡萄球菌之间相互作用的后果
- 批准号:
9230328 - 财政年份:2015
- 资助金额:
$ 33.77万 - 项目类别:
Early airway innate immune responses to F. tularensis
对土拉弗朗西斯菌的早期气道先天免疫反应
- 批准号:
8305636 - 财政年份:2011
- 资助金额:
$ 33.77万 - 项目类别:
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responses
人中性粒细胞、磷脂酶 A2 和金黄色葡萄球菌:微生物靶标和反应
- 批准号:
8195608 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别:
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responses
人中性粒细胞、磷脂酶 A2 和金黄色葡萄球菌:微生物靶标和反应
- 批准号:
7791569 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别:
Human neutrophils and Staphylcoccus aureus: microbial targets and responses
人类中性粒细胞和金黄色葡萄球菌:微生物靶标和反应
- 批准号:
8762232 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Electronic Cigarettes: Emerging Ingredients, Acids, Toxicants, and Indicators of Non-Tobacco Nicotine
电子烟:新兴成分、酸、有毒物质和非烟草尼古丁指标
- 批准号:
10884691 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
Intranasal Nanodelivery of Oxytocin to Treat Morphine Addiction in HIV Patients by Gene Editing
通过基因编辑鼻内纳米递送催产素治疗 HIV 患者吗啡成瘾
- 批准号:
9411292 - 财政年份:2017
- 资助金额:
$ 33.77万 - 项目类别:
Early airway innate immune responses to F. tularensis
对土拉弗朗西斯菌的早期气道先天免疫反应
- 批准号:
8305636 - 财政年份:2011
- 资助金额:
$ 33.77万 - 项目类别:
Influenza therapy by Au-nanorod 5'PPP-NS1-siRNA/cDNA targeting of bronchial cells
Au-nanorod 5PPP-NS1-siRNA/cDNA 靶向支气管细胞的流感治疗
- 批准号:
7897618 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别:
Influenza therapy by Au-nanorod 5'PPP-NS1-siRNA/cDNA targeting of bronchial cells
Au-nanorod 5PPP-NS1-siRNA/cDNA 靶向支气管细胞的流感治疗
- 批准号:
7688443 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别: